Hence, we prepared pegylated CMCS modified with an NGR peptide (CMCS-PEG-NGR, CPN) as a charge-reversible material to coat the MSN loaded with DOX (DOX/MSN-CPN) to achieve high accumulation and effective release of drugs at the tumor site (Scheme 1 and Figure S1). Here, CPN1 is linked to neoplasm.